Moreover, insights into the tumor microenvironment, as provided by Cappellesso et al., underline the therapeutic potential of targeting entities like the bicarbonate transporter SLC4A4 to bolster the efficacy of immunotherapies [66]. The gene discussed is SLC4A4; the disease is neoplasm.